Literature DB >> 2936763

Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.

P Bockenstedt, J M Greenberg, R I Handin.   

Abstract

von Willebrand factor (vWF) is a large, multimeric glycoprotein that helps platelets adhere to vascular subendothelium. Although vWF binding to platelet receptors and connective tissue constituents is of fundamental importance in adhesion, there is little information regarding the nature of these vWF binding sites. In this paper, we have compared the structural requirements for vWF binding with platelet glycoprotein Ib (GpIb), heparin, and collagen and have shown that fragments derived from large vWF multimers retain biologic activity. We have shown that a 440,000-D subunit produced by disulfide reduction and alkylation of vWF polymer binds to platelet GpIb. When analyzed by polyacrylamide gel electrophoresis and Sepharose CL6B chromatography, the 440,000-D vWF oligomer is a dimer of the 220,000 subunit of fully reduced native vWF. This vWF dimer competes with 125I-vWF for binding to GpIb with an IC50 of 100 micrograms/ml (227 nM). The GpIb binding domain on vWF was further localized by digestion of native vWF polymers with Staphylococcal V8 protease. A 285,000-D fragment of vWF multimer was separated from heterogeneous 210,000-225,000-D fragments by its ability to bind to heparin. The 285,000-D fragment that bound to heparin Sepharose was composed of two disulfide-linked 175,000- and 115,000-D polypeptides. The heterogeneous fragments contained disulfide-linked 96,000, 66,000, and 53,000-D polypeptides when analyzed on polyacrylamide gel electrophoresis. The 285,000-D fragment competed with 125I-vWF for binding to GpIb with an IC50 of 22 micrograms/ml (77 nM), while the other fragments did not compete for binding. Neither the vWF dimer nor the proteolytic fragments competed with native 125I-vWF polymer for binding to collagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936763      PMCID: PMC423458          DOI: 10.1172/JCI112369

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

Authors:  J P Allain; H A Cooper; R H Wagner; K M Brinkhous
Journal:  J Lab Clin Med       Date:  1975-02

3.  Decreased adhesion of platelets to subendothelium in von Willebrand's disease.

Authors:  T B Tschopp; H J Weiss; H R Baumgartner
Journal:  J Lab Clin Med       Date:  1974-02

4.  Factors affecting the interactions of collagen molecules as observed by in vitro fibril formation. II. Effects of species and concentration of anions.

Authors:  T Hayashi; Y Nagai
Journal:  J Biochem       Date:  1973-08       Impact factor: 3.387

5.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

Authors:  V T Turitto; H J Weiss; T S Zimmerman; I I Sussman
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

8.  Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.

Authors:  H R Gralnick; S B Williams; B S Coller
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

9.  Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.

Authors:  J D Olson; W J Brockway; D N Fass; M A Magnuson; E J Bowie
Journal:  Am J Clin Pathol       Date:  1975-02       Impact factor: 2.493

10.  Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.

Authors:  W P Houdijk; K S Sakariassen; P F Nievelstein; J J Sixma
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more
  4 in total

1.  O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.

Authors:  J A Carew; S M Quinn; J H Stoddart; D C Lynch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

3.  Poly(Lactic Acid) Blends with Poly(Trimethylene Carbonate) as Biodegradable Medical Adhesive Material.

Authors:  Shuang Zhang; Hongli Li; Mingwei Yuan; Minglong Yuan; Haiyun Chen
Journal:  Int J Mol Sci       Date:  2017-09-28       Impact factor: 5.923

4.  SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis.

Authors:  Julia Tilburg; Daniëlle M Coenen; Gaia Zirka; Sophie Dólleman; Annemarie M van Oeveren-Rietdijk; Mieke F A Karel; Hetty C de Boer; Judith M E M Cosemans; Henri H Versteeg; Pierre E Morange; Bart J M van Vlijmen; Chrissta X Maracle; Grace M Thomas
Journal:  J Thromb Haemost       Date:  2020-05-15       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.